SSB
EBS icon

Sandy Spring Bank’s Emergent Biosolutions EBS Stock Holding History

Sandy Spring Bank’s Portfolio EBS Stock Details EBS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-175
Closed -$9K – 1221
2021
Q3 		$9K Hold
175
– – ﹤0.01% 889
2021
Q2 		$11K Hold
175
– – ﹤0.01% 876
2021
Q1 		$16K Hold
175
– – ﹤0.01% 708
2020
Q4 		$16K Buy
175
+150
+600% +$13.8K ﹤0.01% 668
2020
Q3 		$3K Buy
+25
New +$2.69K ﹤0.01% 777
2019
Q2 		– Sell
-350
Closed -$18K – 835
2019
Q1 		$18K Buy
+350
New +$20.6K ﹤0.01% 597

Other funds holding EBS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Sandy Spring Bank's EBS Position: Q4 2021 in Review

Sandy Spring Bank sold out of Emergent Biosolutions (EBS) in Q4 2021, closing a stake of 175 shares — an estimated $9K sold.

Sandy Spring Bank first reported a position in EBS in Q1 2019 and held it in 6 quarters. The position peaked at $18K in Q1 2019. 254 funds tracked by Wall St. Rank hold EBS as of Q4 2021.

  • Sandy Spring Bank reported no remaining Emergent Biosolutions position as of Q4 2021 after selling out during the quarter.
  • Sandy Spring Bank sold 175 Emergent Biosolutions shares in Q4 2021, an estimated $9K.
  • Sandy Spring Bank first reported a position in Emergent Biosolutions in Q1 2019 and held it in 6 quarters.
  • Sandy Spring Bank's Emergent Biosolutions position peaked at $18K in Q1 2019.
  • 254 funds tracked by Wall St. Rank held Emergent Biosolutions as of Q4 2021.

Based on Sandy Spring Bank's 13F filing for Q4 2021, filed 11 Feb 2022.